Qizheng Tibetan Medicine Pain Relief Patch Wins “West Lake Award—Most Popular Star Product Among Pharmacies” Prize

Release time:

2024-04-11 09:33

On April 9, the results of the “West Lake Award—Outstanding Figures in China’s Pharmaceutical Industry” were solemnly announced at the 2024 Wuzhen Health Conference. Liu Kai, President of Qizheng Tibetan Medicine, was honorably listed among the winners, and the company’s product, Qizheng Pain-Relieving Plaster, also received the “West Lake Award—Most Popular Star Product Among Pharmacies” award.

It is reported that the “West Lake Award—Most Popular Star Product Among Pharmacies” is a special award established for this conference. Focusing primarily on retail pharmacy channels and meeting the daily healthcare needs of the public, the award aims to identify the star products in the retail sector that boast the greatest influence, sales performance, competitiveness, and public attention. By leveraging these products to strengthen brands and using brand building to drive high-quality development of China’s pharmaceutical industry, the award seeks to promote the optimization and upgrading of the pharmaceutical industry.

The company stated that Qizheng Xiaotong Paste, as one of Qizheng Tibetan Medicine’s core products, is a time-tested Tibetan prescription—a nationally classified confidential formula and a national medical insurance and essential medicine product. It has been awarded the Second Prize for National Scientific and Technological Progress and the Gold Award at the Geneva International Invention Exhibition. Thanks to its remarkable efficacy in promoting blood circulation, resolving blood stasis, reducing swelling, and relieving pain, the product consistently ranks among the industry leaders in market share and single-product sales volume. In 2023, Qizheng Xiaotong Paste was successively honored with the titles of “2022 China Over-the-Counter Drug Golden Best-Selling Product,” “2023 China Over-the-Counter Drug Golden Best-Selling Product,” and “Influential Brand in the Pharmaceutical Industry,” and was also included in the “2022-2023 China Household Essential Medicines List.”

Since its establishment, Qizheng Tibetan Medicine has consistently focused on the research and development, production, and sales of Tibetan medicines. Relying on an independent and comprehensive supply, R&D, production, and sales system, as well as a product portfolio covering multiple disease areas, Qizheng Tibetan Medicine has continuously met market demands and earned widespread market recognition. At this year’s 2024 Wuzhen Health Conference, themed “Co-creating a Brighter Future” and centered around the spirit of “Resilience and Adapting to Change,” Qizheng Tibetan Medicine also received several awards, including the title of “Advanced Member Unit for Self-Medication Education in the 2022-2023 Period.” (Tian Limin)

Reporting media: Shanghai Securities Journal·China Securities Network

Report link: https://ggjd.cnstock.com/company/scp_ggjd/tjd_bbdj/202404/5216482.htm

Qizheng Tibetan Medicine has been awarded the title of “Advanced Member Unit for Self-Medication Education in 2022-2023.”

Qizheng Tibetan Medicine Public Welfare Initiative: From the Plateau to the Interior—Innovating While Preserving Tradition